Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ORIC | Oric Pharmaceuticals, Inc. | PRESIDENT AND CEO, Director | $12.5M | -$1.26M | -9.15% | Mar 6, 2024 |
FDMT | 4D Molecular Therapeutics, Inc. | Director | May 21, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|